Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Rapid Micro Biosystems (RPID) Shares Outstanding (2020 - 2025)

Rapid Micro Biosystems' Shares Outstanding history spans 6 years, with the latest figure at $40.0 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 652.82% to $40.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.0 million, a 652.82% increase, with the full-year FY2025 number at $40.0 million, up 652.82% from a year prior.
  • Shares Outstanding hit $40.0 million in Q4 2025 for Rapid Micro Biosystems, roughly flat from $39.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for RPID hit a ceiling of $34.4 billion in Q3 2021 and a floor of $5.3 million in Q2 2023.
  • Historically, Shares Outstanding has averaged $1.8 billion across 5 years, with a median of $36.5 million in 2022.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 9610086.21% in 2021 and later tumbled 99.89% in 2022.
  • Tracing RPID's Shares Outstanding over 5 years: stood at $34.6 million in 2021, then crashed by 83.93% to $5.6 million in 2022, then skyrocketed by 568.06% to $37.1 million in 2023, then crashed by 85.69% to $5.3 million in 2024, then soared by 652.82% to $40.0 million in 2025.
  • Business Quant data shows Shares Outstanding for RPID at $40.0 million in Q4 2025, $4.5 million in Q3 2025, and $39.6 million in Q2 2025.